Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Reports from the same study

Selected source-checked relationships. Keep these records separate, but do not count each report as an independent study or add their participant totals.

Johns Hopkins MDD waiting-list trial

The primary report and 12-month follow-up describe the same trial cohort. Follow-up does not provide a new randomized comparison. Checked 2026-11-03.

Registry identity: NCT03181529.

Coverage is incomplete. Missing links do not establish independence. Relationship data and source evidence (JSON).

Bibliographic context

Journal
Journal of psychopharmacology (Oxford, England)
Date
2022-02-01
Source
PubMed
DOI
10.1177/02698811211073759
PubMed
35166158
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:48:05 UTC
Metadata last checked
2026-08-09 08:28:21 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression2026-11-01Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression2026-11-01Substantial Treatment-Seeking Interest, Narrow Eligibility: Diagnostic Heterogeneity and External Validity in the PRIDE Psilocybin Trial-Relevance to Precision Psychiatry2026-10-26Clinical Evidence on Psilocybin and Its Representation in Media Reporting2026-10-20The New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy2026-10-01Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review2026-09-10Beyond Efficacy Signals: Regulatory, Methodological, and Translational Challenges in Clinical Research on Ketamine and Psilocybin in Psychiatry2026-09-01PSYCHEDELICS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND DEPRESSION: A REVIEW OF CLINICAL TRIALS2026-08-31No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study2026-07-23Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex2026-06-28DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish2026-06-18Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis2026-06-15Psilocybin: Chemical Foundations and Emerging Therapeutic Potential2026-06-01Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial2026-06-01Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats2026-06-01Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial2026-05-27Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression2026-05-15The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21

Related papers

No close related records were found yet.